See more : Sambhaav Media Limited (SAMBHAAV.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Tandem Diabetes Care, Inc. (TNDM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tandem Diabetes Care, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Heat Biologics, Inc. (HTBX) Income Statement Analysis – Financial Results
- Brunswick Corporation 6.375% No (BC-PC) Income Statement Analysis – Financial Results
- PT Kapuas Prima Coal Tbk (ZINC.JK) Income Statement Analysis – Financial Results
- OCI N.V. (OCI.AS) Income Statement Analysis – Financial Results
- Sichuan Languang Development Co., Ltd. (600466.SS) Income Statement Analysis – Financial Results
Tandem Diabetes Care, Inc. (TNDM)
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 747.72M | 801.22M | 702.80M | 498.83M | 362.31M | 183.87M | 107.60M | 84.25M | 72.85M | 49.72M | 29.01M | 2.47M | 0.00 |
| Cost of Revenue | 380.03M | 388.23M | 326.58M | 238.31M | 168.09M | 94.04M | 63.51M | 60.66M | 46.27M | 34.47M | 22.84M | 3.82M | 0.00 |
| Gross Profit | 367.69M | 412.99M | 376.22M | 260.52M | 194.21M | 89.82M | 44.09M | 23.59M | 26.58M | 15.25M | 6.17M | -1.35M | 0.00 |
| Gross Profit Ratio | 49.17% | 51.54% | 53.53% | 52.23% | 53.60% | 48.85% | 40.98% | 28.00% | 36.49% | 30.67% | 21.26% | -54.48% | 0.00% |
| Research & Development | 169.67M | 139.11M | 92.05M | 63.57M | 45.20M | 29.23M | 20.66M | 18.81M | 16.96M | 15.79M | 11.08M | 9.01M | 8.26M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 86.38M | 82.83M | 78.62M | 75.12M | 43.82M | 22.62M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00M | 1.50M | 700.00K | 68.00K | 0.00 |
| SG&A | 352.50M | 335.68M | 261.51M | 204.90M | 165.74M | 105.23M | 86.38M | 82.83M | 78.62M | 75.12M | 44.52M | 22.69M | 15.95M |
| Other Expenses | 78.75M | -4.00K | 0.00 | 0.00 | -7.88M | -77.93M | -10.08M | -5.41M | -3.40M | -3.79M | 44.52M | 22.69M | 0.00 |
| Operating Expenses | 600.92M | 474.80M | 353.56M | 268.48M | 210.93M | 134.45M | 107.04M | 101.64M | 95.58M | 90.91M | 55.60M | 31.70M | 24.21M |
| Cost & Expenses | 980.95M | 863.03M | 680.15M | 506.79M | 379.03M | 228.50M | 170.55M | 162.30M | 141.85M | 125.39M | 78.44M | 35.52M | 24.21M |
| Interest Income | 22.86M | 6.06M | 674.00K | 1.57M | 3.27M | 1.46M | 239.00K | 296.00K | 337.00K | 112.00K | 6.64K | 2.43K | 13.66K |
| Interest Expense | 9.88M | 4.31M | 4.31M | 12.15M | 78.00K | 7.58M | 11.34M | 5.71M | 3.74M | 3.90M | 4.71M | 2.53M | 542.18K |
| Depreciation & Amortization | 15.72M | 14.33M | 13.85M | 10.45M | 6.07M | 5.82M | 6.87M | 5.49M | 4.83M | 4.39M | 3.17M | 2.03M | 1.28M |
| EBITDA | -194.66M | -72.31M | 36.50M | -13.03M | -18.45M | -109.16M | -54.82M | -72.27M | -63.84M | -71.16M | -55.26M | -28.46M | -22.92M |
| EBITDA Ratio | -26.03% | -3.84% | 3.22% | -1.60% | -4.62% | -24.27% | -58.50% | -92.64% | -94.72% | -152.17% | -159.48% | -1,253.23% | 0.00% |
| Operating Income | -233.23M | -61.81M | 8.81M | -7.96M | -16.72M | -44.63M | -62.94M | -78.05M | -69.00M | -75.66M | -49.43M | -33.05M | -24.21M |
| Operating Income Ratio | -31.19% | -7.71% | 1.25% | -1.60% | -4.62% | -24.27% | -58.50% | -92.64% | -94.72% | -152.17% | -170.42% | -1,335.44% | 0.00% |
| Total Other Income/Expenses | 12.98M | -4.00K | -6.75M | -28.33M | -7.88M | -77.93M | -10.08M | -5.41M | -3.40M | -3.79M | -13.70M | 33.00K | -1.30M |
| Income Before Tax | -220.25M | -92.85M | 15.90M | -36.28M | -24.60M | -122.56M | -73.03M | -83.46M | -72.41M | -79.45M | -63.14M | -33.02M | -25.51M |
| Income Before Tax Ratio | -29.46% | -11.59% | 2.26% | -7.27% | -6.79% | -66.66% | -67.87% | -99.07% | -99.39% | -159.79% | -217.67% | -1,334.11% | 0.00% |
| Income Tax Expense | 2.36M | 1.74M | 335.00K | -1.90M | 149.00K | 51.00K | 8.00K | -15.00K | 10.00K | 71.00K | 4.71M | 2.53M | 542.18K |
| Net Income | -222.61M | -94.59M | 15.57M | -34.38M | -24.75M | -122.61M | -73.03M | -83.45M | -72.42M | -79.52M | -63.14M | -33.02M | -25.51M |
| Net Income Ratio | -29.77% | -11.81% | 2.21% | -6.89% | -6.83% | -66.68% | -67.87% | -99.05% | -99.41% | -159.94% | -217.67% | -1,334.11% | 0.00% |
| EPS | -3.43 | -1.47 | 0.25 | -0.56 | -0.42 | -2.55 | -12.86 | -27.30 | -25.04 | -34.17 | -214.61 | -26.32 | -20.34 |
| EPS Diluted | -3.43 | -1.47 | 0.24 | -0.56 | -0.42 | -2.55 | -12.86 | -27.30 | -25.04 | -34.17 | -214.61 | -26.32 | -20.34 |
| Weighted Avg Shares Out | 64.90M | 64.15M | 63.00M | 60.99M | 58.51M | 48.13M | 5.68M | 3.06M | 2.89M | 2.33M | 294.20K | 1.25M | 1.25M |
| Weighted Avg Shares Out (Dil) | 64.97M | 64.15M | 64.35M | 60.99M | 58.51M | 48.13M | 5.68M | 3.06M | 2.89M | 2.33M | 294.20K | 1.25M | 1.25M |
Reasons to Retain TNDM Stock in Your Portfolio for Now
Tandem Diabetes Care Announces Upcoming Conference Presentations
TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket
Tandem Diabetes Care, Inc. (TNDM) Q3 2024 Earnings Conference Call Transcript
Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
Tandem Diabetes Care Announces Upcoming Conference Participation
Down -21.69% in 4 Weeks, Here's Why Tandem Diabetes Care (TNDM) Looks Ripe for a Turnaround
Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
Why Tandem Diabetes Care Stock Took It on the Chin Tuesday
Source: https://incomestatements.info
Category: Stock Reports